Chimerix's (CMRX) recently approved "weaponized smallpox" vaccine (Brincidofovir) has previously failed TWO different Phase 3 trials with all-cause deaths in the treatment group occurring at 150% of the rate for placebo group, 15% versus 10%. - Conspiracies

Chimerix's (CMRX) recently approved "weaponized smallpox" vaccine (Brincidofovir) has previously failed TWO different Phase 3 trials with all-cause deaths in the treatment group occurring at 150% of the rate for placebo group, 15% versus 10%. (www.fiercebiotech.com)

posted 3 years ago by Error_usernotfound 3 years ago by Error_usernotfound +33 / -0

8 comments

8 comments share save hide report block hide replies

You're viewing a single comment thread. View all comments, or full comment thread.

Comments (8)

sorted by:

▲ 1 ▼

– Error_usernotfound [S] 1 point 3 years ago +1 / -0

Brand name is Tembexa *Notice the disclaimer about increased mortality rates

Chimerix licensed Cidofovir from Gilead Sciences and received funding from NIH

permalink save report block reply

▲ 1 ▼

– Error_usernotfound [S] 1 point 3 years ago +1 / -0

former Chimerix CEO George Painter connected to new pill-based COVID-19 treatment

Chimerix has ties to Bilderberg Group, Rumsfeld, and Council on Foreign Relations, Dr. Ralph Baric...just to name a few. SOURCE: opencorporates, lilsis, and brave search.